A detailed history of Berkshire Capital Holdings Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Berkshire Capital Holdings Inc holds 10 shares of LLY stock, worth $7,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 16,490 99.94%
Holding current value
$7,480
Previous $14.9 Million 99.95%
% of portfolio
0.0%
Previous 6.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $12.7 Million - $15.8 Million
-16,480 Reduced 99.94%
10 $8,000
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $11.9 Million - $15 Million
16,480 Added 164800.0%
16,490 $14.9 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $5,922 - $7,922
10 New
10 $7,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Berkshire Capital Holdings Inc Portfolio

Follow Berkshire Capital Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Capital Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Capital Holdings Inc with notifications on news.